Quest Diagnostics Stock (DGX) Likely to Remain Under Pressure until December 2025
Quest Diagnostics (Ticker: DGX) was one of the standout performers following the COVID-19 market crash in 2020, soaring nearly 75% within just a few months after the March 2020 low. Since then, DGX has continued to show decent relative strength — but that may be changing. According to the latest forecast from EquiPredict Analytics, DGX…